Ország: Szingapúr
Nyelv: angol
Forrás: HSA (Health Sciences Authority)
Roche Diagnostics Asia Pacific Pte Ltd
Class B IVD
Roche Diagnostics GmbH
Clinical toxicology
Roche Diagnostics Cobas Integra Cannabinoids II (THCII) is an in vitro diagnostic test for the semiquantitative and qualitative detection of cannabinoids in human urine at cutoff concentrations of 20 ng/mL, 50 ng/mL, and 100 ng/mL on COBAS INTEGRA systems
Models: COBAS INTEGRA Cannabinoids - 03046753190, Preciset DAT Plus I - 03304671190, Preciset DAT Plus II - 03304680190, Control Set DAT I - 03312950190, Control Set DAT II - 03312968190, Control Set DAT III - 03312976190, Control Set DAT Clinical - 04500873190, C.f.a.s. DAT Qualitative Plus - 03304698190, C.f.a.s. DAT Qualitative Plus Clinical - 04590856190, cobas Integra 400 plus - 03245233001, cobas Integra 400 plus software version 3.5.2 - 05636957001, cobas Integra 400 plus software version 3.4.4 - 05215242001, Cleaner - 20754765322, CLEAN Cleaner Cassette - 20764337322, NaCl Diluent 9% - 20756350322, SI2 Serum Index Gen.2 - 04489365190, SDR II COBAS FP Sample Dilution Reagent II - 20720720322, MULTI Single use reagent carrier - 04593138190, Waste Container COBAS Integra 400 - 21046179001, Cup Sample White with hole - 21045318001, Cup Sample Blue with hole - 21044869001, Cuvette COBAS Integra - 21043862001
2014-01-24